Phase II Trial of Bortezomib and Vorinostat in Mantle Cell and Diffuse Large B-Cell Lymphomas
Phase of Trial: Phase II
Latest Information Update: 16 Aug 2018
At a glance
- Drugs Bortezomib (Primary) ; Vorinostat (Primary)
- Indications Diffuse large B cell lymphoma; Mantle-cell lymphoma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 26 Mar 2018 Status changed from active, no longer recruiting to completed.
- 30 Apr 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.